ENGLEWOOD, Fla. SinoFresh HealthCare earlier this week announced its non-binding letter-of-intent signed with National Starch and Chemical Co. to develop new versions of popular allergy-related over-the-counter medicines.
The company is targeting March 2008 for launch.
The new products will utilize National Starch’s proprietary patented Proloc bio-adhesive technology to deliver the drug formulations.
“In the United States, our current nasal spray has been aimed at helping the 37 million people who suffer from Chronic Sinusitis. By developing new and improved allergy-related formulations, we expect to help an additional 50 million people who suffer from allergies,” stated SinoFresh chief executive officer Charles Fust.